Can you take Wegovy short term — and what happens when you stop?

What does the research show happens when you stop Wegovy early?

The STEP 1 trial, published in the New England Journal of Medicine, ran for 68 weeks and showed an average body-weight reduction of around 15% in adults with obesity or overweight taking semaglutide 2.4mg alongside lifestyle support. A follow-on study then tracked participants after treatment stopped. Within a year, most people had regained around two-thirds of the weight they had lost.

That pattern isn't unique to semaglutide. Obesity is a chronic condition involving appetite hormones, metabolic set points and gut signalling. Wegovy works by activating GLP-1 receptors to reduce hunger and slow gastric emptying. Remove the medicine and those signals reassert themselves. The biology doesn't get trained out of you over a few months.

None of this means short-term use is pointless. Some people use a shorter course to get traction before a planned lifestyle intervention, or ahead of a medical procedure. But anyone going in expecting permanent results from a brief course will likely be disappointed. The Wegovy treatment overview covers the full evidence picture in more detail.

Is there a minimum or maximum time you have to take it?

The Wegovy licence doesn't set a hard minimum course length, but the titration schedule matters. Starting at 0.25mg and stepping up to the 2.4mg maintenance dose takes around four to five months. Stopping before you reach a therapeutic dose means you may never have experienced the medicine's full effect. A prescriber would generally want to see at least six months at the maintenance dose before drawing conclusions about whether treatment is working, in line with NICE guidance, if less than 5% of body weight has been lost after six months on the highest tolerated dose, continuing treatment is formally reviewed.

On the NHS, eligibility for Wegovy is governed by NICE's recommendation (TA875), which specifies a maximum of two years within a specialist weight management service. Private prescribing isn't capped in the same way, but a responsible prescriber reassesses at every repeat to confirm ongoing suitability and clinical benefit.

If you're thinking about a shorter course for a specific reason (a wedding, a holiday, a medical assessment) it's worth having that conversation openly with a prescriber. They can advise on realistic expectations. That's exactly the kind of question our clinical team fields regularly.

What should you expect if you do stop Wegovy?

Practically, the medicine clears your system over a few weeks after the last dose. Most people notice hunger returning and fullness signals becoming less pronounced. Some find the habits they've built (smaller portions, slower eating, less snacking) persist for a while. Others find the change in appetite quite sudden.

There's no clinical danger in simply stopping Wegovy (it isn't associated with withdrawal in the way some medicines are), but stopping abruptly without a plan for maintaining dietary changes is associated with faster weight regain. If stopping is the intention, it's worth speaking to your prescriber about what support to put in place first.

Injection timing and scheduling questions sometimes come up at the same time as duration questions. If you've ever found yourself wondering whether taking your Wegovy shot a day early is something your schedule allows for, that page explains what flexibility exists week to week. And if you've wondered about daily routines around the tablet form, the Wegovy pill is now MHRA-approved in the UK as of June 2026 for those who'd prefer not to inject, no fridge required, which makes it easier to fit into a morning routine before the kettle's even boiled.

Does short-term Wegovy make sense for you specifically?

That's genuinely an individual question. People in good health with a modest amount of weight to lose, a clear short-term trigger, and a strong lifestyle plan around the medicine may use a shorter course thoughtfully and constructively. People with more weight to manage, or metabolic conditions that worsen without sustained intervention, are less likely to benefit from stopping early.

Cost is sometimes the honest reason behind the short-term question. Wegovy is not cheap, and that's worth acknowledging. If cost is the driver, it's worth understanding what's included in a private prescription price before comparing numbers, the Wegovy price page sets out how the UK private market is structured. For context on the wider landscape of options, the weight-loss treatment overview compares what's licensed and available.

If you're working out whether Wegovy makes sense for your situation at all, the BMI eligibility guidance is a practical starting point. The NHS medicines information on semaglutide and the NICE appraisal (TA875) are both worth reading if you want the official clinical framing.